(Q24242140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Adjunctive therapies for AIDS dementia complex (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

main subject

dementia

0 references

AIDS dementia complex

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Jibril Abdulmalik

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Jubril O Abdulmalik

series ordinal

2

0 references

publication date

16 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

CD006496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

A phase I/II trial of nimodipine for HIV-related neurologic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Human immunodeficiency virus dementia patients in Africa: How many? Who cares? And where to from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

HIV-1 associated dementia: symptoms and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

The neuropathogenesis of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Neurological complications of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Factors associated with incident human immunodeficiency virus-dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Neuroprotective therapy for HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Neuroprotective and anti-human immunodeficiency virus activity of minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Improvement in AIDS patients on peptide T

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Neurological complications of HIV infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Epidemiology of AIDS Dementia Complex in Europe

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Clinical trials in HIV-associated cognitive impairment: Cognitive and functional outcomes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Treatment of early AIDS dementia in intravenous drug users: high versus low dose peptide T

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

Prospects for therapy of HIV-associated neurologic diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006496.PUB2

7 January 2021

10.1002/14651858.CD006496.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18646159%20AND%20SRC:MED&resulttype=core&format=json

release_dbl2pkbevbbfzbkpw2u4myrni4

11 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dbl2pkbevbbfzbkpw2u4myrni4

24 November 2022

mapped directly with Wikidata item

1 reference